← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 0.99 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 0.99 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 0.99 CYP46A1 Overexpression Gene Therapy (CYP46A1) — 0.98 SASP-Mediated Complement Cascade Amplification (C1Q/C3) — 0.98 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 Selective Acid Sphingomyelinase Modulation Therapy (SMPD1) — 0.98 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 0.98 Nutrient-Sensing Epigenetic Circuit Reactivation (SIRT1) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli (CYP46A1) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.95 Closed-loop transcranial focused ultrasound to restore hippo (PVALB) — 0.95 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.94 Epigenetic Priming Ketone Protocol (HDAC2/HDAC3) — 0.94 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.93 Closed-loop tACS targeting EC-II PV interneurons to suppress (PVALB) — 0.93 Focused Ultrasound with Microbubble Contrast Agents for Anti (CLDN5/ZO-1 tight junction complex; KDR/VEGFR2) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from (TREM2) — 0.92 Transcriptional Autophagy-Lysosome Coupling (FOXO1) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 TREM2-ASM Crosstalk in Microglial Lysosomal Senescence (SMPD1) — 0.91 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.91
Add
|
× [Archived Hypothesis]
- · - · mechanistic
Composite 0.300
Price $0.30
Evidence For 0
Evidence Against 0
Radar Chart — 10 Dimensions
Score Breakdown
Dimension [Archived Hypothesis] Mechanistic 0.000 Evidence 0.000 Novelty 0.000 Feasibility 0.000 Impact 0.000 Druggability 0.000 Safety 0.000 Competition 0.000 Data 0.000 Reproducible 0.000 KG Connect 0.500
Evidence [Archived Hypothesis] No evidence citations yet
Debate Excerpts [Archived Hypothesis] 4 rounds · quality: 0.81
Theorist # Legacy Pre-Pipeline Hypotheses: Neurodegeneration
---
## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease
**Mechanism:** Misfolded α-synuclein (aSy...
Skeptic # Critical Evaluation of Legacy Pre-Pipeline Hypotheses
## General Methodological Concerns (Cross-Cutting Issues)
Before evaluating individual hypotheses, several systemic weaknesses affect the enti...
Domain Expert # Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses
## Preamble
This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...
Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease",
"description": "TREM2 loss-of-function variants ...
Price History Overlay